252 related articles for article (PubMed ID: 31370326)
1. Genetic Variants in the Promoter Region of the Macrophage Migration Inhibitory Factor are Associated with the Severity of Hepatitis C Virus-Induced Liver Fibrosis.
Wirtz TH; Fischer P; Backhaus C; Bergmann I; Brandt EF; Heinrichs D; Koenen MT; Schneider KM; Eggermann T; Kurth I; Stoppe C; Bernhagen J; Bruns T; Fischer J; Berg T; Trautwein C; Berres ML
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370326
[TBL] [Abstract][Full Text] [Related]
2. TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection.
Sghaier I; Zidi S; Mouelhi L; Ghazoueni E; Brochot E; Almawi WY; Loueslati BY
Br J Biomed Sci; 2019 Jan; 76(1):35-41. PubMed ID: 30421643
[TBL] [Abstract][Full Text] [Related]
3. Macrophage Migration Inhibitory Factor (MIF) Gene Promotor Polymorphism Is Associated with Increased Fibrosis in Biliary Atresia Patients, but Not with Disease Susceptibility.
Sadek KH; Ezzat S; Abdel-Aziz SA; Alaraby H; Mosbeh A; Abdel-Rahman MH
Ann Hum Genet; 2017 Sep; 81(5):177-183. PubMed ID: 28657145
[TBL] [Abstract][Full Text] [Related]
4. IL-28B rs12979860 polymorphism affect the course of chronic hepatitis and the development of HCC in Egyptian patients with hepatitis C type 4.
Attallah AM; Omran D; Marie MS; Abdelrazek M; Salama A; El Essawey R; Mobarak L; Maklad S; Omar A
Br J Biomed Sci; 2018 Oct; 75(4):157-162. PubMed ID: 29914308
[TBL] [Abstract][Full Text] [Related]
5. The role of macrophage migration inhibitory factor in autoimmune liver disease.
Assis DN; Leng L; Du X; Zhang CK; Grieb G; Merk M; Garcia AB; McCrann C; Chapiro J; Meinhardt A; Mizue Y; Nikolic-Paterson DJ; Bernhagen J; Kaplan MM; Zhao H; Boyer JL; Bucala R
Hepatology; 2014 Feb; 59(2):580-91. PubMed ID: 23913513
[TBL] [Abstract][Full Text] [Related]
6. Genotyping Two Promoter Polymorphisms in the MIF Gene: A -794 CATT
Leng L; Siu E; Bucala R
Methods Mol Biol; 2020; 2080():67-84. PubMed ID: 31745872
[TBL] [Abstract][Full Text] [Related]
7. Functional polymorphisms of macrophage migration inhibitory factor as predictors of morbidity and mortality of pneumococcal meningitis.
Savva A; Brouwer MC; Roger T; Valls Serón M; Le Roy D; Ferwerda B; van der Ende A; Bochud PY; van de Beek D; Calandra T
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3597-602. PubMed ID: 26976591
[TBL] [Abstract][Full Text] [Related]
8. Control of progression towards liver fibrosis and hepatocellular carcinoma by SOCS3 polymorphisms in chronic HCV-infected patients.
Jadid FZ; Chihab H; Alj HS; Elfihry R; Zaidane I; Tazi S; Badre W; Marchio A; El Filali KM; Tahiri M; Saile R; Pineau P; Ezzikouri S; Benjelloun S
Infect Genet Evol; 2018 Dec; 66():1-8. PubMed ID: 30172885
[TBL] [Abstract][Full Text] [Related]
9. A Macrophage Migration Inhibitory Factor Polymorphism Is Associated with Autoimmune Hepatitis Severity in US and Japanese Patients.
Assis DN; Takahashi H; Leng L; Zeniya M; Boyer JL; Bucala R
Dig Dis Sci; 2016 Dec; 61(12):3506-3512. PubMed ID: 27696094
[TBL] [Abstract][Full Text] [Related]
10. Independent and additive interaction between polymorphisms of tumor necrosis factor α-308 and lymphotoxin α+252 on risk of hepatocellular carcinoma related to hepatitis B.
Tsai JF; Chen SC; Lin ZY; Dai CY; Huang JF; Yu ML; Chuang WL
Kaohsiung J Med Sci; 2017 Sep; 33(9):453-457. PubMed ID: 28865603
[TBL] [Abstract][Full Text] [Related]
11. Macrophage migration inhibitory factor (MIF): genetic evidence for participation in early onset and early stage rheumatoid arthritis.
Llamas-Covarrubias MA; Valle Y; Bucala R; Navarro-Hernández RE; Palafox-Sánchez CA; Padilla-Gutiérrez JR; Parra-Rojas I; Bernard-Medina AG; Reyes-Castillo Z; Muñoz-Valle JF
Cytokine; 2013 Mar; 61(3):759-65. PubMed ID: 23402792
[TBL] [Abstract][Full Text] [Related]
12. Independent and additive interaction between tumor necrosis factor β +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study.
Jeng JE; Wu HF; Tsai MF; Tsai HR; Chuang LY; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Tsai JF
Asian Pac J Cancer Prev; 2014; 15(23):10209-15. PubMed ID: 25556449
[TBL] [Abstract][Full Text] [Related]
13. A genetic role for macrophage migration inhibitory factor (MIF) in adult-onset Still's disease.
Wang FF; Huang XF; Shen N; Leng L; Bucala R; Chen SL; Lu LJ
Arthritis Res Ther; 2013; 15(3):R65. PubMed ID: 23721694
[TBL] [Abstract][Full Text] [Related]
14. Influence of the human MIF promoter polymorphism on hepatocellular carcinoma prognosis.
Yuan T; Tang C; Chen M; Deng S; Chen P
Genet Mol Res; 2013 Jan; 12(4):6629-35. PubMed ID: 23315862
[TBL] [Abstract][Full Text] [Related]
15. PNPLA3 rs738409 G allele carriers with genotype 1b HCV cirrhosis have lower viral load but develop liver failure at younger age.
Senkerikova R; Frankova S; Jirsa M; Kreidlova M; Merta D; Neroldova M; Chmelova K; Spicak J; Sperl J
PLoS One; 2019; 14(9):e0222609. PubMed ID: 31527889
[TBL] [Abstract][Full Text] [Related]
16. Gene polymorphisms of macrophage migration inhibitory factor affect susceptibility to chronic hepatitis B virus infection in an Iranian cohort.
Moudi B; Heidari Z; Mahmoudzadeh-Sagheb H; Hashemi M
Microbiol Immunol; 2016 Jun; 60(6):390-6. PubMed ID: 27079941
[TBL] [Abstract][Full Text] [Related]
17. Increased serum levels and promoter polymorphisms of macrophage migration inhibitory factor in schizophrenia.
Okazaki S; Hishimoto A; Otsuka I; Watanabe Y; Numata S; Boku S; Shimmyo N; Kinoshita M; Inoue E; Ohmori T; Someya T; Sora I
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Apr; 83():33-41. PubMed ID: 29305329
[TBL] [Abstract][Full Text] [Related]
18. Association between Toll-Like Receptor 3 (TLR3) rs3775290, TLR7 rs179008, TLR9 rs352140 and Chronic HCV.
Mosaad YM; Metwally SS; Farag RE; Lotfy ZF; AbdelTwab HE
Immunol Invest; 2019 Apr; 48(3):321-332. PubMed ID: 30321082
[TBL] [Abstract][Full Text] [Related]
19. Association of Macrophage Migration Inhibitory Factor Polymorphisms with Total Plasma IgE Levels in Patients with Atopic Dermatitis in Korea.
Kim JS; Choi J; Hahn HJ; Lee YB; Yu DS; Kim JW
PLoS One; 2016; 11(9):e0162477. PubMed ID: 27598332
[TBL] [Abstract][Full Text] [Related]
20. CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer.
Silvestri L; Sonzogni L; De Silvestri A; Gritti C; Foti L; Zavaglia C; Leveri M; Cividini A; Mondelli MU; Civardi E; Silini EM
Int J Cancer; 2003 Apr; 104(3):310-7. PubMed ID: 12569554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
